109 filings
ARS
2023 FY
RNA
Avidity Biosciences Inc
26 Apr 24
Annual report to shareholders
4:21pm
DEFA14A
RNA
Avidity Biosciences Inc
26 Apr 24
Additional proxy soliciting materials
4:17pm
DEF 14A
RNA
Avidity Biosciences Inc
Definitive proxy
26 Apr 24
4:12pm
S-3ASR
RNA
Avidity Biosciences Inc
2 Apr 24
Automatic shelf registration
4:15pm
D
RNA
Avidity Biosciences Inc
19 Mar 24
$400.21 mm in equity / options / securities to be acquired, sold $400.21 mm, 45 investors
4:47pm
8-K
4exgc v29ma3njdf
4 Mar 24
Regulation FD Disclosure
7:07am
S-8
cncdp29
29 Feb 24
Registration of securities for employees
4:19pm
8-K
h5ya4txibjba 8zgc9
29 Feb 24
Avidity Biosciences Announces Oversubscribed $400 Million Private Placement
4:06pm
S-3ASR
0cnzqrd9 iq
28 Feb 24
Automatic shelf registration
5:32pm
8-K
bawmlw95kf97k4ba
28 Feb 24
Avidity Biosciences Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Highlights
4:08pm
8-K
1my2i kf9vkm6
5 Jan 24
Departure of Directors or Certain Officers
8:36am
8-K
m4u35dawjlv3
14 Dec 23
Other Events
4:14pm
8-K
i2xwqph4aya
12 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:22pm
8-K
62lls4acqd 00i
28 Nov 23
Entry into a Material Definitive Agreement
6:31am
8-K
i2ubos0b
8 Nov 23
Avidity Biosciences Reports Third Quarter 2023 Financial Results and Recent Highlights
4:08pm
8-K
o8k2vlgv
10 Oct 23
Other Events
6:53am
8-K
p0piyml 4sp8
8 Aug 23
Avidity Biosciences Reports Second Quarter 2023 Financial Results and Recent Highlights
4:09pm